Competitive Technologies Announces Sale of 12 Calmare(R) Pain Therapy Medical Devices to U.S. Military

Technology News Friday August 19, 2011 07:27 —Biomedical

Competitive Technologies, Inc. (OTCQX:CTTC) today announced that it has received an order to ship 12 Calmare(R) devices valued at over $600,000 to nine separate U.S. military medical facilities in the U.S. and overseas. The devices will be shipped within the next 30 days.

About Competitive Technologies, Inc.

Competitive Technologies is a global leader in developing and commercializing innovative products and technologies. CTTC is multifaceted, providing distribution, patent and technology transfer, sales and licensing services. CTTC's staff is focused on the needs of customers and matching those requirements with commercially viable products or technology solutions.

CTTC is the licensed worldwide distributor of the non-invasive Calmare(R) pain therapy medical device, which incorporates the biophysical "Scrambler Therapy(TM)" technology developed in Italy by CTTC's client, Professor Giuseppe Marineo to treat neuropathic pain, including cancer pain. The Calmare(R) device is currently being manufactured for sale by CTTC's partner, GEOMC Co., Ltd. of Seoul, Korea. For more information on the device, visit www.calmarett.com. Visit CTTC's website: www.competitivetech.net.

Statements made about our future expectations are forward-looking statements and subject to risks and uncertainties as described in our most recent Annual Report on Form 10-K for the year ended July 31, 2010, filed with the SEC on October 27, 2010, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

CONTACT: Direct inquiries to: Jean Wilczynski, IR Services, LLC
860.434.2465 / info@corpirservices.com

เว็บไซต์นี้มีการใช้งานคุกกี้ ศึกษารายละเอียดเพิ่มเติมได้ที่ นโยบายความเป็นส่วนตัว และ ข้อตกลงการใช้บริการ รับทราบ